TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: DIRECT (DIsulfiram REsponse as add-on to ChemoTherapy in Recurrent) Glioblastoma: A Randomized Controlled Trial
Brief Summary: Disulfiram (Antabuse®) is a well-tolerated, cheap, generic drug that has been in use since the 1950s to treat alcoholism. There is now an increasing amount of independent preclinical data to support disulfiram as an anticancer agent. The potency of disulfiram as an anticancer agent seems strengthened by copper.

The investigators aim is to investigate disulfiram and copper-supplement as add-on treatment in glioblastoma patients with recurrence receiving alkylating chemotherapy.


Options:
A: Arm Label: Group 1a: Bevacizumab Naïve with Bevacizumab + rindopepimut.; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab, Drug: Rindopepimut (CDX-110) with GM-CSF | Arm Label: Group 1b: Bevacizumab Naïve with Bevacizumab + KLH control; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab, Drug: KLH | Arm Label: Group 2 and 2C: Refractory to Bevacizumab; Type: EXPERIMENTAL; Interventions: Drug: Bevacizumab, Drug: Rindopepimut (CDX-110) with GM-CSF | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Group 1a: Bevacizumab Naïve with Bevacizumab + rindopepimut., Group 1b: Bevacizumab Naïve with Bevacizumab + KLH control, Group 2 and 2C: Refractory to Bevacizumab | Intervention Type: DRUG; Name: Rindopepimut (CDX-110) with GM-CSF; Assigned to Arm(s): Group 1a: Bevacizumab Naïve with Bevacizumab + rindopepimut., Group 2 and 2C: Refractory to Bevacizumab | Intervention Type: DRUG; Name: KLH; Assigned to Arm(s): Group 1b: Bevacizumab Naïve with Bevacizumab + KLH control
B: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: VB-111 + bevacizumab | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bevacizumab | Intervention Type: DRUG; Name: VB-111 + bevacizumab; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: Bevacizumab; Assigned to Arm(s): Arm 2
C: Arm Label: Surgical Group; Type: EXPERIMENTAL; Interventions: Drug: PD 0332991 (pre-surgery), Drug: PD 0332991, Procedure: Resection as clinical care | Arm Label: Non-surgical group; Type: EXPERIMENTAL; Interventions: Drug: PD 0332991 | Intervention Type: DRUG; Name: PD 0332991 (pre-surgery); Assigned to Arm(s): Surgical Group | Intervention Type: DRUG; Name: PD 0332991; Assigned to Arm(s): Non-surgical group, Surgical Group | Intervention Type: PROCEDURE; Name: Resection as clinical care; Assigned to Arm(s): Surgical Group
D: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Alkylating Agents | Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Drug: Disulfiram, Dietary Supplement: Copper, Drug: Alkylating Agents | Intervention Type: DRUG; Name: Disulfiram; Assigned to Arm(s): Experimental | Intervention Type: DIETARY_SUPPLEMENT; Name: Copper; Assigned to Arm(s): Experimental | Intervention Type: DRUG; Name: Alkylating Agents; Assigned to Arm(s): Control, Experimental

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Influence of a Virtual Reality Environment on Pain Perception During Exercises for Patients With Chronic Non-specific Low Back Pain: A Randomized Controlled Trial
Brief Summary: Immersion in a virtual reality environment has been shown to reduce pain during a variety of painful medical procedures, such as wound care for burn patients and dental care. Often, serious games are used to distract patients from this painful procedures. Recently, serious games have also been developed for patients with low back pain. Because patients with low back pain frequently experience pain during exercises, the investigators hypothesize that exercising with serious games can reduce the pain intensity and the time spent thinking of pain during exercises. To test this hypothesis, the investigators will conduct a randomized controlled trial where two groups will be compared: the experimental group will perform one session of exercises with serious games, while the control group will perform one session of the same exercises without the serious games.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Yoga | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-care book recommendations | Intervention Type: BEHAVIORAL; Name: Yoga; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Self-care book recommendations; Assigned to Arm(s): 3
B: Arm Label: Virtual reality group; Type: EXPERIMENTAL; Interventions: Other: Virtual reality exercise group | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional exercise group (control group) | Intervention Type: OTHER; Name: Virtual reality exercise group; Assigned to Arm(s): Virtual reality group | Intervention Type: OTHER; Name: Conventional exercise group (control group); Assigned to Arm(s): Control group
C: Intervention Type: PROCEDURE; Name: High intensity motor control exercise (deadlift); Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Low intensity motor control exercise; Assigned to Arm(s): N/A
D: Arm Label: BB; Type: ACTIVE_COMPARATOR; Interventions: Other: Mild, Other: Mild vs. NC | Arm Label: BB+A; Type: EXPERIMENTAL; Interventions: Other: Moderate, Other: Mild, Other: Mild vs. NC, Other: Moderate vs. NC | Arm Label: DBC; Type: EXPERIMENTAL; Interventions: Other: Moderate, Other: Moderate vs. NC | Arm Label: PMU; Type: EXPERIMENTAL; Interventions: Other: Moderate, Other: Moderate vs. NC | Arm Label: NC; Type: PLACEBO_COMPARATOR; Interventions: Other: Mild vs. NC, Other: Moderate vs. NC | Intervention Type: OTHER; Name: Moderate; Assigned to Arm(s): BB+A, DBC, PMU | Intervention Type: OTHER; Name: Mild; Assigned to Arm(s): BB, BB+A | Intervention Type: OTHER; Name: Mild vs. NC; Assigned to Arm(s): BB, BB+A, NC | Intervention Type: OTHER; Name: Moderate vs. NC; Assigned to Arm(s): BB+A, DBC, NC, PMU

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The immediate post cesarean section IUD insertion is a further step towards spreading more compliance to females in developing countries, with rapid increase in population size


Options:
A: Arm Label: early insertion; Type: EXPERIMENTAL; Interventions: Drug: early insertion | Arm Label: conventional insertion; Type: ACTIVE_COMPARATOR; Interventions: Drug: conventional insertion | Intervention Type: DRUG; Name: early insertion; Assigned to Arm(s): early insertion | Intervention Type: DRUG; Name: conventional insertion; Assigned to Arm(s): conventional insertion
B: Arm Label: Immediate postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Arm Label: 6 week postpartum IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T380A Intrauterine Device | Intervention Type: DEVICE; Name: Copper T380A Intrauterine Device; Assigned to Arm(s): 6 week postpartum IUD insertion, Immediate postpartum IUD insertion
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Etonogestrel contraceptive implant | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Etonogestrel contraceptive implant | Intervention Type: DRUG; Name: Etonogestrel contraceptive implant; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Etonogestrel contraceptive implant; Assigned to Arm(s): 2
D: Arm Label: PostPlacental IUD insertion; Type: EXPERIMENTAL; Interventions: Device: Copper T intrauterine device | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Copper T intrauterine device; Assigned to Arm(s): PostPlacental IUD insertion

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Controlled Trial Assessing The Impact Of An Intermittent Energy Restricted Diet On Weight Loss, Insulin Sensitivity and Heart Rate Variability In Men and Women With Central Obesity
Brief Summary: An intermittent energy restricted (IER) diet may modify cardio-metabolic disease risk factors compared to an energy-matched continuous energy restricted (CER) diet. A randomised controlled parallel design trial will determine the impact of a short-term IER diet (2 consecutive days of very low calorie diet (VLCD), 5 days moderate energy restriction each week for a 4 week period), compared to a CER diet, on insulin sensitivity in healthy (disease-free) subjects with central obesity.


Options:
A: Arm Label: Caloric restriction only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Caloric restriction only | Arm Label: Caloric restriction plus TRF morning; Type: EXPERIMENTAL; Interventions: Behavioral: Caloric restriction plus TRF morning | Arm Label: Caloric restriction plus TRF night; Type: EXPERIMENTAL; Interventions: Behavioral: Caloric restriction plus TRF night | Intervention Type: BEHAVIORAL; Name: Caloric restriction only; Assigned to Arm(s): Caloric restriction only | Intervention Type: BEHAVIORAL; Name: Caloric restriction plus TRF morning; Assigned to Arm(s): Caloric restriction plus TRF morning | Intervention Type: BEHAVIORAL; Name: Caloric restriction plus TRF night; Assigned to Arm(s): Caloric restriction plus TRF night
B: Arm Label: Intermittent Fasting; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Meal Replacement | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Meal Replacement; Assigned to Arm(s): Intermittent Fasting
C: Arm Label: Intermittent Energy Restriction; Type: EXPERIMENTAL; Interventions: Behavioral: Intermittent Energy Restriction | Arm Label: Continuous Energy Restriction; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Continuous Energy Restriction | Intervention Type: BEHAVIORAL; Name: Intermittent Energy Restriction; Assigned to Arm(s): Intermittent Energy Restriction | Intervention Type: BEHAVIORAL; Name: Continuous Energy Restriction; Assigned to Arm(s): Continuous Energy Restriction
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Calorie restriction; Type: EXPERIMENTAL; Interventions: Other: Calorie restriction | Intervention Type: OTHER; Name: Calorie restriction; Assigned to Arm(s): Calorie restriction

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Three-armed Randomised Controlled Trial of Non-participants in an Organised Cervical Cancer Screening Programme
Brief Summary: The trial will evaluate the effect on participation in organised screening programme of a human papilloma virus (HPV) self-sampling kit directly mailed home or mailed on demand compared with the standard second reminder for regular screening.


Options:
A: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group I; Type: EXPERIMENTAL; Interventions: Behavioral: self-regulation | Intervention Type: BEHAVIORAL; Name: self-regulation; Assigned to Arm(s): Intervention Group I
B: Arm Label: Intervention group 1; Type: EXPERIMENTAL; Interventions: Behavioral: HPV self-sampling kit mailed directly | Arm Label: Intervention group 2; Type: EXPERIMENTAL; Interventions: Behavioral: HPV self-sampling kit on demand | Arm Label: Intervention group 3; Type: EXPERIMENTAL; Interventions: Behavioral: Second reminder | Intervention Type: BEHAVIORAL; Name: HPV self-sampling kit mailed directly; Assigned to Arm(s): Intervention group 1 | Intervention Type: BEHAVIORAL; Name: HPV self-sampling kit on demand; Assigned to Arm(s): Intervention group 2 | Intervention Type: BEHAVIORAL; Name: Second reminder; Assigned to Arm(s): Intervention group 3
C: N/A
D: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Other: RESTORE II Program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: RESTORE II Program; Assigned to Arm(s): Intervention Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION)
Brief Summary: A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in participants with Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atenolol | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Lisinopril | Intervention Type: DRUG; Name: Lisinopril; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Atenolol; Assigned to Arm(s): 1
B: Arm Label: Vadadustat; Type: EXPERIMENTAL; Interventions: Drug: Vadadustat | Arm Label: Darbepoetin alfa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Darbepoetin alfa | Intervention Type: DRUG; Name: Vadadustat; Assigned to Arm(s): Vadadustat | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin alfa
C: Arm Label: HD treated with standard dialysate; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard dialysate (StDi) | Arm Label: post-dilution oHDF with standard dialysate; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard dialysate (StDi) | Arm Label: pre-dilution oHDF with citrate dialysate; Type: EXPERIMENTAL; Interventions: Device: Citrate dialysate (CiDi) | Arm Label: HD treated with citrate dialysate; Type: EXPERIMENTAL; Interventions: Device: Citrate dialysate (CiDi) | Arm Label: post-dilution oHDF with citrate dialysate; Type: EXPERIMENTAL; Interventions: Device: Citrate dialysate (CiDi) | Arm Label: pre-dilution oHDF with standard dialysate; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard dialysate (StDi) | Intervention Type: DEVICE; Name: Citrate dialysate (CiDi); Assigned to Arm(s): HD treated with citrate dialysate, post-dilution oHDF with citrate dialysate, pre-dilution oHDF with citrate dialysate | Intervention Type: DEVICE; Name: Standard dialysate (StDi); Assigned to Arm(s): HD treated with standard dialysate, post-dilution oHDF with standard dialysate, pre-dilution oHDF with standard dialysate
D: Arm Label: Exercise training; Type: EXPERIMENTAL; Interventions: Other: Exercise | Arm Label: No exercise; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual Treatment | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise training | Intervention Type: OTHER; Name: Usual Treatment; Assigned to Arm(s): No exercise

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION)
Brief Summary: A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in participants with Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)


Options:
A: Arm Label: Vadadustat; Type: EXPERIMENTAL; Interventions: Drug: Vadadustat | Arm Label: Darbepoetin alfa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Darbepoetin alfa | Intervention Type: DRUG; Name: Vadadustat; Assigned to Arm(s): Vadadustat | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin alfa
B: Arm Label: BAY85-3934 (25mg); Type: EXPERIMENTAL; Interventions: Drug: BAY85-3934 | Arm Label: BAY85-3934 (50mg); Type: EXPERIMENTAL; Interventions: Drug: BAY85-3934 | Arm Label: BAY85-3934 (75mg); Type: EXPERIMENTAL; Interventions: Drug: BAY85-3934 | Arm Label: Darbepoetin alfa; Type: ACTIVE_COMPARATOR; Interventions: Biological: Darbepoetin alfa | Intervention Type: DRUG; Name: BAY85-3934; Assigned to Arm(s): BAY85-3934 (25mg), BAY85-3934 (50mg), BAY85-3934 (75mg) | Intervention Type: BIOLOGICAL; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin alfa
C: Arm Label: HIF-PHI; Type: EXPERIMENTAL; Interventions: Drug: HIF-PHI | Arm Label: Epoetin alfa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Epoetin Alfa | Intervention Type: DRUG; Name: HIF-PHI; Assigned to Arm(s): HIF-PHI | Intervention Type: DRUG; Name: Epoetin Alfa; Assigned to Arm(s): Epoetin alfa
D: Arm Label: FG-4592; Type: EXPERIMENTAL; Interventions: Drug: FG-4592 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: FG-4592; Assigned to Arm(s): FG-4592 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of a Mobile Health Approach to Reduce Barriers to Cervical Cancer Screening in Tanzania
Brief Summary: The purpose of this study is to determine whether motivational text messages and/or travel vouchers are effective in increasing cervical cancer screening rates in urban and rural regions of Northern Tanzania.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Contraceptive app instant messages, Other: Mobile phone app | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: Mobile phone app | Intervention Type: BEHAVIORAL; Name: Contraceptive app instant messages; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Mobile phone app; Assigned to Arm(s): Control, Intervention
B: Arm Label: Motivational SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational SMS | Arm Label: Travel Voucher; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational SMS, Behavioral: Travel Voucher | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational SMS; Assigned to Arm(s): Motivational SMS, Travel Voucher | Intervention Type: BEHAVIORAL; Name: Travel Voucher; Assigned to Arm(s): Travel Voucher
C: Arm Label: Standard of Care (SoC); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SoC + iTab; Type: ACTIVE_COMPARATOR; Interventions: Device: SoC + iTab | Intervention Type: DEVICE; Name: SoC + iTab; Assigned to Arm(s): SoC + iTab
D: Arm Label: ARM 1 = TEXT MESSAGING SUPPORT; Type: EXPERIMENTAL; Interventions: Drug: nPEP, Behavioral: Text Messaging Support | Arm Label: ARM 2 = NO TEXT MESSAGING SUPPORT; Type: EXPERIMENTAL; Interventions: Drug: nPEP | Arm Label: ARM 3 = NURSE-LED nPEP; Type: EXPERIMENTAL; Interventions: Drug: nPEP, Other: Nurse-Led nPEP | Arm Label: ARM 4 = ID PHYSICIAN-LED nPEP,; Type: ACTIVE_COMPARATOR; Interventions: Drug: nPEP | Intervention Type: DRUG; Name: nPEP; Assigned to Arm(s): ARM 1 = TEXT MESSAGING SUPPORT, ARM 2 = NO TEXT MESSAGING SUPPORT, ARM 3 = NURSE-LED nPEP, ARM 4 = ID PHYSICIAN-LED nPEP, | Intervention Type: BEHAVIORAL; Name: Text Messaging Support; Assigned to Arm(s): ARM 1 = TEXT MESSAGING SUPPORT | Intervention Type: OTHER; Name: Nurse-Led nPEP; Assigned to Arm(s): ARM 3 = NURSE-LED nPEP

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of a Mobile Health Approach to Reduce Barriers to Cervical Cancer Screening in Tanzania
Brief Summary: The purpose of this study is to determine whether motivational text messages and/or travel vouchers are effective in increasing cervical cancer screening rates in urban and rural regions of Northern Tanzania.


Options:
A: Arm Label: Kilkari; Type: EXPERIMENTAL; Interventions: Other: Kilkari | Arm Label: Comparison; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Kilkari; Assigned to Arm(s): Kilkari
B: Arm Label: Motivational SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational SMS | Arm Label: Travel Voucher; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational SMS, Behavioral: Travel Voucher | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational SMS; Assigned to Arm(s): Motivational SMS, Travel Voucher | Intervention Type: BEHAVIORAL; Name: Travel Voucher; Assigned to Arm(s): Travel Voucher
C: Arm Label: Reminder module (SMS and Phone call); Type: EXPERIMENTAL; Interventions: Behavioral: Reminder module (SMS and Phone call) | Arm Label: Photovoice; Type: EXPERIMENTAL; Interventions: Behavioral: Photovoice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Reminder module (SMS and Phone call); Assigned to Arm(s): Reminder module (SMS and Phone call) | Intervention Type: BEHAVIORAL; Name: Photovoice; Assigned to Arm(s): Photovoice
D: Arm Label: 1. One way SMS messages.; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 2. Two Way SMS messages; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 3. One way automated calls.; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 4.Two way interactive automated calls; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS messages and automated calls | Arm Label: 5. Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SMS messages and automated calls; Assigned to Arm(s): 1. One way SMS messages., 2. Two Way SMS messages, 3. One way automated calls., 4.Two way interactive automated calls

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of a Mobile Health Approach to Reduce Barriers to Cervical Cancer Screening in Tanzania
Brief Summary: The purpose of this study is to determine whether motivational text messages and/or travel vouchers are effective in increasing cervical cancer screening rates in urban and rural regions of Northern Tanzania.


Options:
A: Arm Label: Physical activity; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Arm Label: Cancer screening; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cancer screening | Intervention Type: BEHAVIORAL; Name: Physical activity; Assigned to Arm(s): Physical activity | Intervention Type: BEHAVIORAL; Name: Cancer screening; Assigned to Arm(s): Cancer screening
B: Arm Label: Motivational SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational SMS | Arm Label: Travel Voucher; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational SMS, Behavioral: Travel Voucher | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Motivational SMS; Assigned to Arm(s): Motivational SMS, Travel Voucher | Intervention Type: BEHAVIORAL; Name: Travel Voucher; Assigned to Arm(s): Travel Voucher
C: Arm Label: CHWs facilitated Self-Sampling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CHW and Self-sampling for Cervical Cancer | Arm Label: Mailed Self-Sampler; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mailed Self Sampler | Intervention Type: BEHAVIORAL; Name: CHW and Self-sampling for Cervical Cancer; Assigned to Arm(s): CHWs facilitated Self-Sampling | Intervention Type: BEHAVIORAL; Name: Mailed Self Sampler; Assigned to Arm(s): Mailed Self-Sampler
D: Intervention Type: DEVICE; Name: online health information journal; Assigned to Arm(s): N/A

Answer: B